
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: Prospective cohort study based on the ADVANCE (action in diabetes and vascular disease: Preterax and diamicron modified-release controlled evaluation) trial.J. 10.1016/j.jacc.2010.04.067 [DOI] [PMC free article] [PubMed] [Google Scholar] Counterfeits and imitations of Viagra® and Cialis® tablets: Trends and risks to public health. A decision-analysis tool for benefit-risk assessment of nonprescription drugs.
Improving the decision-making process for nonprescription drugs: A framework for benefit-risk assessment. 10.1038/clpt.2011.231 [DOI] [PubMed] [Google Scholar] Breau R. H., Mcgrath P. J., Norman R.
| Side Effect | Frequency | Severity | Recommendations |
|---|---|---|---|
| Headache | Common | Mild to Moderate | Hydrate and rest |
| Flushing | Common | Mild | Cool compress, avoid hot beverages |
| Indigestion | Moderate | Mild | Take with food |
| Muscle aches | Rare | Mild | Consult doctor if persistent |
W. (2003). Assessing self-help issues for patients with prostate cancer, interstitial cystitis, erectile dysfunction and urinary diversion. Estimating the prevalence of sexual dysfunction using the new ICD-11 guidelines. 10.3238/arztebl.2020.0653 [DOI] [PMC free article] [PubMed] [Google Scholar] Campbell N., Clark J.
G., Hutchings D. C., Woodward M., Rahimi K., Rutter M. K., Kirby M., et al. Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality. Evaluation of endothelial function with brachial artery ultrasound in men with or without erectile dysfunction and classified as intermediate risk according to the Framingham Score.J. P., Stecher V. J., Goldstein I. Internet-ordered viagra (sildenafil citrate) is rarely genuine.J. The dangers of sexual enhancement supplements and counterfeit drugs to “treat” erectile dysfunction. 10.21037/tau.2016.10.04 [DOI] [PMC free article] [PubMed] [Google Scholar] Chu P. L., McFarland W., Gibson S., Weide D., Henne J., Miller P., et al. Viagra use in a community-recruited sample of men who have sex with men, San Francisco. EDEUS, a real-life study on the users of phosphodiesterase type 5 inhibitors: Prevalence, perceptions, and health care-seeking behavior among European men with a focus on 2nd-generation avanafil. 10.1016/j.esxm.2017.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar] Crespo-Leiro M. G., Anker S.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Generic | 60mg | 360 + 10 Pills | 570.52€ 543.35€ | |
| Tadalista Super Active | 20mg | 270 + 30 Pills | 661.49€ 629.99€ | |
| Cialis Generic | 40mg | 60 + 6 Pills | 130.98€ 124.74€ | |
| Tadalista Super Active | 20mg | 180 + 20 Pills | 521.59€ 496.75€ | |
| Cialis Generic | 2.5mg | 270 + 10 Pills | 199.64€ 190.13€ | |
| Cialis Generic | 40mg | 90 + 6 Pills | 171.35€ 163.19€ | |
| Cialis Generic | 40mg | 20 Pills | 59.47€ 56.64€ | |
| Cialis Generic | 5mg | 270 + 10 Pills | 205.81€ 196.01€ | |
| Cialis Generic | 10mg | 120 + 6 Pills | 178.49€ 169.99€ | |
| Cialis Generic | 5mg | 90 + 6 Pills | 115.91€ 110.39€ | |
| Cialis Generic | 2.5mg | 10 Pills | 28.51€ 27.15€ | |
| Cialis Generic | 5mg | 20 Pills | 41.99€ 39.99€ | |
| Cialis Generic | 40mg | 30 + 4 Pills | 74.97€ 71.40€ |
D., Maggioni A.
P., Coats A. J., Filippatos G., Ruschitzka F., et al. European society of cardiology heart failure long-term registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. The prevalence of bother, acceptance, and need for help in men with erectile dysfunction.J. 10.1111/j.1743-6109.2005.20364.x [DOI] [PubMed] [Google Scholar] A review of the evidence considering whether it is worthwhile to support self-management.
R., Tseng L. J., Collins S. (2006). Impact of erectile dysfunction on confidence, self-esteem and relationship satisfaction after 9 months of sildenafil citrate treatment. 10.1016/j.juro.2006.07.019 [DOI] [PubMed] [Google Scholar] Althof S.
E., Rubio-Aurioles E., Kingsberg S., Zeigler H., Wong D. G., Burns P. (2010). Impact of tadalafil once daily in men with erectile dysfunction--including a report of the partners' evaluation. 10.1016/j.urology.2009.11.066 [DOI] [PubMed] [Google Scholar] Anderson S. Effective Erectile Dysfunction (ED) Treatment Enables Men to Enjoy Better Sex: The Importance of Erection Hardness, Psychological Well-Being, and Partner Satisfaction.
Across the domains there were no additional risk mitigation measures considered to be essential beyond the wording on the carton and in the PIL. There were suggestions to include warnings about newer medications for heart failure, such as vericiguat on the packaging and PIL. The discussion highlighted points about drug-drug interactions in general and the balance required in terms of how much information to include on the PIL, such as the trade and generic names. It was agreed that discussion with a GP or pharmacist about any potential interactions with their other medication would be beneficial and that this could be a recommendation in the PIL. Based on this thorough and systematic assessment of the evidence for the incremental benefits and risks of making tadalafil available without prescription in Germany, the consensus amongst clinical experts was that the incremental risks would be small.
They would either be unlikely to occur or, if more likely to occur, would have little clinical impact. There was high level agreement that the risks are sufficiently manageable, so even if there were differing opinions regarding the magnitude of benefits, the average risk evaluation appeared significantly lower than the potential benefits. With thanks to Harald Weigmann and Mohamed Amessou from Sanofi and to the team from Hamell Communications. The process was sponsored by Sanofi who provided funding to support the extensive literature review, allowed access to their post-marketing safety data, clinical trial data and clinical pharmacology data and provided funding to facilitate the meeting. However, the Group Delphi process and evaluation of the benefits/risks was independent of Sanofi. Enables Men Enjoy Better Sex Importance Erection Hardness, Psychol. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies.J. 10.1016/j.jacc.2011.06.024 [DOI] [PubMed] [Google Scholar] Guideline on legal status for the supply to the patient of centrally authorised medicinal products. (EMA): Committee for medicinal products for human use (CHMP). European survey shows alarmingly low awareness of erectile dysfunction. Undertreatment of erectile dysfunction: Claims analysis of 6.2 million patients.J. 015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the tadalafil 40mg diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): Endorsed by: Association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). 10.1161/circulationaha.108.839274 [DOI] [PubMed] [Google Scholar] J., Clark Wr, Brady E., Ma S., Dgetluck N., Klise Sr, et al. Hemodynamic effects of once-daily tadalafil in men with signs and symptoms of benign prostatic hyperplasia on concomitant α1-adrenergic antagonist therapy: results of a multicenter randomized, double-blind, placebo-controlled trial. Epidemiology update of erectile dysfunction in eight countries with high burden. Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: A systematic review and meta-analysis.
Recent TV advertising was believed to have raised awareness of ED and reduced inhibition thresholds to seek treatment. If tadalafil were prescription-free, it was considered likely that the topic of ED would be more publicly discussed, and the feelings of embarrassment reduced. It was widely agreed that the consumer would be unaware if the product was counterfeited or not, but if it were available to buy in pharmacies, patients would have less reason to go to unreliable internet sources. The New Zealand example of reduced counterfeit packages following reclassification was discussed and considered to be potentially applicable in Germany. Only three risks scored above 1, the potential drug-drug interaction with riociguat which scored 2.2, potential misuse by men without ED which scored 1.6 and use with nitrates which scored 1.3.
Riociguat is a relatively new drug used in the treatment of the rare condition of pulmonary arterial hypertension or more recently chronic thromboembolic pulmonary hypertension. The score reflected the moderate degree of clinical impact such a drug-drug reaction would have, but there was general agreement that this scenario would be unlikely because men would be under specialist clinical supervision and would also see the risk mitigation warning messages on the packaging and PIL. Potential misuse by men without ED was considered moderately likely to increase if tadalafil were to be available without prescription, but the clinical impact of this overuse was deemed to be low. The risk of drug-drug interactions with nitrates was considered of low likelihood and to have low clinical impact, largely because they are now rarely used in Germany. The warnings on the package and label were also felt to be sufficient though the panel recommended that men be directed to discuss their medication with a pharmacist or doctor if they are unsure about what they are taking. 10.1007/s11255-017-1644-5 [DOI] [PMC free article] [PubMed] [Google Scholar] Gott M., Galena E., Hinchliff S., Elford H. (2004). Opening a can of worms: GP and practice nurse barriers to talking about sexual health in primary care. Help-Seeking interval in erectile dysfunction: Analysis of attitudes, beliefs, and factors affecting treatment-seeking interval in Turkish men with previously untreated erectile dysfunction.
No members of Sanofi actively participated in the meeting and discussion of the evidence or interacted with the clinical experts. Editorial support was provided by Fiona Hammond and Alison Carr of Hamell Communications, United Kingdom, and was funded by Sanofi. Sanofi had no role in the design, execution, or interpretation of the Group Delphi process or in the writing of the paper. The authors received payment from Sanofi for their participation in the group Delphi meeting but no payment was received in relation to the writing or review of the paper. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.
Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Althof S. E., O'Leary M. P., Cappelleri J. C., Crowley A. 10.1001/archinternmed.2011.440 [DOI] [PubMed] [Google Scholar] Study lvft (H6D-EW-LVFT): A pharmacodynamic study to evaluate the interaction between 20 mg tadalafil and doxazosin, an alpha 1 adrenergic antagonist. Study LVAE (H6D-EW-LVAE): Randomised, placebo-controlled, subject and investigator-blind, four-period cross-over study to investigate the pharmacodynamic interaction between alcohol and tadalafil in healthy volunteers.